共 50 条
- [21] Changing COVID-19 outcomes in patients with rheumatic disease-are we really getting better at this? LANCET RHEUMATOLOGY, 2021, 3 (02): : E88 - E90
- [22] Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease Rheumatology International, 2020, 40 : 2117 - 2118
- [29] Determinants of COVID-19 disease severity in patients with underlying rheumatic disease Clinical Rheumatology, 2020, 39 : 2789 - 2796